Moreover, the group achieved the identification of the 20 nM-epidermal growth factor receptor (EGFR), which is a 180 kDa prognostic protein biomarker associated with lung, colon, and breast cancer, in 5% (v/v) fetal bovine serum (FBS), suggesting the potential applications of molecular robots in nanomedicine. This evidence concerns the gene EGFR and breast carcinoma.